English
Back
Download
Log in to access Online Inquiry
Back to the Top

$Fulgent Genetics (FLGT.US)$Revenue surged by 12 times in 20...

$Fulgent Genetics (FLGT.US)$Revenue surged by 12 times in 2020, continued to grow by 1.4 times in 2021, typical pandemic stock. In 2022, there was a significant decline of 37.6%. Operating profit also reached a peak of 0.68 billion in 2021, then dropped sharply by 73% in 2022. Net income saw a substantial decrease of 72% in 2022.
Revenue declined by 79% in Q1 2023, both operating profit and net income entered into a loss range. Currently, the market cap is 1.15 billion, lacking investment value.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
See Original
Report
5193 Views
Comment
Sign in to post a comment
    588
    Followers
    35
    Following
    3212
    Visitors
    Follow
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.